Exploring the relationship between Treg-mediated risk in COPD and lung cancer through Mendelian randomization analysis and scRNA-seq data integration

被引:0
|
作者
Zhang, Dengfeng [1 ]
Liu, Haitao [2 ]
Zhao, Fangchao [1 ]
Guo, Pengfei [1 ]
Li, Jing [1 ]
Lu, Tianxing [1 ]
Li, Zhirong [1 ]
Li, Shujun [1 ]
机构
[1] Hebei Med Univ, Prov Ctr Clin Lab, Dept Thorac Surg, Hosp 2, Shijiazhuang, Peoples R China
[2] Inner Mongolia Univ, Coll Life Sci, Hohhot, Peoples R China
关键词
scRNA-seq; Mendelian randomization; Lung cancer; Regulatory T cells; Chronic obstructive Pulmonary disease; OBSTRUCTIVE PULMONARY-DISEASE; T-CELLS; RECURRENCE; EXPRESSION; EMPHYSEMA; IL-17A;
D O I
10.1186/s12885-024-12076-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Evidence from observational studies suggests an association between chronic obstructive pulmonary disease (COPD) and lung cancer. The potential interactions between the immune system and the lungs may play a causative role in COPD and lung cancer and offer therapeutic prospects. However, the causal association and the immune-mediated mechanisms between COPD and lung cancer remain to be determined. Methods We employed a two-sample Mendelian randomization (MR) approach to investigate the causal association between COPD and lung cancer. Additionally, we examined whether immune cell signals were causally related to lung cancer, as well as whether COPD was causally associated with immune cell signals. Furthermore, through two-step Mendelian randomization, we investigated the mediating effects of immune cell signals in the causal association between COPD and lung cancer. Leveraging publicly available genetic data, our analysis included 468,475 individuals of European ancestry with COPD, 492,803 individuals of European ancestry with lung cancer, and 731 immune cell signatures of European ancestry. Additionally, we conducted single-cell transcriptome sequencing analysis on COPD, lung cancer, and control samples to validate our findings. Findings We found a causal association between COPD and lung cancer (odds ratio [OR] = 1.63, 95% confidence interval [CI] = 1.31-2.02, P-value < 0.001). We also observed a causal association between COPD and regulatory T cells (odds ratio [OR] = 1.19, 95% confidence interval [CI] = 1.01-1.40, P-value < 0.05), as well as a causal association between regulatory T cells and lung cancer (odds ratio [OR] = 1.02, 95% confidence interval [CI] = 1.002-1.045, P-value < 0.05). Furthermore, our two-step Mendelian randomization analysis demonstrated that COPD is associated with lung cancer through the mediation of regulatory T cells. These findings were further validated through single-cell sequencing analysis, confirming the mediating role of regulatory T cells in the association between COPD and lung cancer. Interpretation As far as we are aware, we are the first to combine single-celled immune cell data with two-sample Mendelian randomization. Our analysis indicates a causal association between COPD and lung cancer, with regulatory T cells playing an intermediary role.
引用
收藏
页数:9
相关论文
共 43 条
  • [1] Relationship between lung function and lung cancer risk: a pooled analysis of cohorts plus Mendelian randomization study
    Su, Zixuan
    Jiang, Yu
    Li, Caichen
    Zhong, Ran
    Wang, Runchen
    Wen, Yaokai
    Liang, Hengrui
    Chen, Zhuxing
    He, Jianxing
    Liang, Wenhua
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147 (10) : 2837 - 2849
  • [2] A Comprehensive Comparison between Primary Liver Cancer and Liver Metastases through scRNA-Seq Data Analysis
    Hao, Shuang
    Chen, Liqun
    Du, Wenhui
    Sun, Huiyan
    METABOLITES, 2024, 14 (02)
  • [3] Exploring the link between walking and lung cancer risk: a two-stage Mendelian randomization analysis
    Chen, Fangjun
    Lin, Chutong
    Gu, Xing
    Ning, Yingze
    He, Huayu
    Qiang, Guangliang
    BMC PULMONARY MEDICINE, 2024, 24 (01)
  • [4] Exploring the link between walking and lung cancer risk: a two-stage Mendelian randomization analysis
    Fangjun Chen
    Chutong Lin
    Xing Gu
    Yingze Ning
    Huayu He
    Guangliang Qiang
    BMC Pulmonary Medicine, 24
  • [5] Relationship between lung function and lung cancer risk: a pooled analysis of cohorts plus Mendelian randomization study
    Zixuan Su
    Yu Jiang
    Caichen Li
    Ran Zhong
    Runchen Wang
    Yaokai Wen
    Hengrui Liang
    Zhuxing Chen
    Jianxing He
    Wenhua Liang
    Journal of Cancer Research and Clinical Oncology, 2021, 147 : 2837 - 2849
  • [6] Exploring the relationship between the interleukin family and lung adenocarcinoma through Mendelian randomization and RNA sequencing analysis
    Zhi, Fei-Hang
    Liu, Wei
    Yang, Hao-Shuai
    Luo, Hong-He
    Feng, Yan-Fen
    Lei, Yi-Yan
    DISCOVER ONCOLOGY, 2024, 15 (01)
  • [7] Plasma proteometabolome in lung cancer: exploring biomarkers through bidirectional Mendelian randomization and colocalization analysis
    Dong, Bo
    Wang, Mengyao
    Li, Kaixiu
    Li, Zuwei
    Liu, Lunxu
    Shen, Shensi
    HUMAN MOLECULAR GENETICS, 2024, 33 (19) : 1688 - 1696
  • [8] Immune cells mediated the causal relationship between the gut microbiota and lung cancer: a Mendelian randomization study
    Chen, Zhiting
    Wang, Zhe
    Ma, Hao
    Bao, Hejing
    Jiang, Ting
    Yang, Ting
    Ma, Shudong
    FRONTIERS IN MICROBIOLOGY, 2024, 15
  • [9] Unveiling mitophagy-mediated molecular heterogeneity and development of a risk signature model for colorectal cancer by integrated scRNA-seq and bulk RNA-seq analysis
    Gao, Han
    Zou, Qi
    Ma, Linyun
    Cai, Keyu
    Sun, Yi
    Lu, Li
    Ren, Donglin
    Hu, Bang
    GASTROENTEROLOGY REPORT, 2023, 11
  • [10] Assessing the causal relationship between 731 immunophenotypes and the risk of lung cancer: a bidirectional mendelian randomization study
    Xu, Ming
    Li, Chengkai
    Xiang, Liyan
    Chen, Siyue
    Chen, Lin
    Ling, Gongxia
    Hu, Yanqing
    Yang, Lan
    Yuan, Xiang
    Xia, Xiaodong
    Zhang, Hailin
    BMC CANCER, 2024, 24 (01)